Department of Orthopaedic Surgery, Chonnam National University College of Medicine, Chonnam National University Hospital, Gwangju, Republic of Korea.
Department of Orthopaedic Surgery, Good Morning General Hospital, Pyeongtaek, Republic of Korea.
BMC Surg. 2023 Jul 5;23(1):193. doi: 10.1186/s12893-023-02092-6.
Anatomical total shoulder arthroplasty (aTSA) has been used to manage degenerative diseases such as primary osteoarthritis. An increase in the use of this procedure has led to several developments in humeral and glenoid components to improve patient outcomes. This study aimed to compare clinical and radiological outcomes of the newly-introduced convertible metal-backed glenoid components with cemented polyethylene glenoid components in aTSA, and to determine whether the new component would be comparable to a conventional one for reducing the burden of future revision or conversion surgeries.
Medical records of fifty patients who underwent aTSA with at least two years of follow-up were retrospectively reviewed. Eighteen patients received convertible metal-backed glenoid components with vitamin E1-coated liner (MB group), while thirty-two patients received conventional cemented polyethylene glenoid components (PE group). Pre- and postoperative clinical and radiological outcomes (acromion-greater tuberosity angle [AGA] and humeral lateral offset [LO]) at final follow-up were assessed. Radiolucent lines (RLLs) and loosening around the humeral and glenoid components were also evaluated.
Clinical outcomes improved after surgery in both groups (all p < 0.001). The arc of rotation measured by AGA improved postoperatively in both groups (all p < 0.001), and AGA and LO were not different according to the type of glenoid components (all p > 0.05). Overall complication rates including RLLs of PE and MB groups were 43.8% (14/32) and 16.7% (3/18), respectively (p = 0.031). Although the PE group had more RLLs than did the MB group (p < 0.05), related symptoms and/or glenoid implant loosening were not observed in both groups. Subscapularis failure occurred in two patients in the PE group and in one in the MB group.
The convertible metal-backed glenoid implant with vitamin E1-coated liner may be a good alternative for considering the potential for an easier conversion to reverse total shoulder arthroplasty.
解剖型全肩关节置换术(aTSA)已被用于治疗退行性疾病,如原发性骨关节炎。由于该手术的应用日益增加,人们对肱骨和肩胛盂部件进行了多项改进,以改善患者的预后。本研究旨在比较新引入的可转换金属背衬肩胛盂组件与 aTSA 中骨水泥聚乙烯肩胛盂组件的临床和影像学结果,并确定新组件是否能与传统组件一样,降低未来翻修或转换手术的负担。
回顾性分析了 50 例接受 aTSA 治疗且至少随访 2 年的患者的病历。18 例患者接受了维生素 E1 涂层衬垫的可转换金属背衬肩胛盂组件(MB 组),32 例患者接受了传统骨水泥聚乙烯肩胛盂组件(PE 组)。评估术前和术后的临床和影像学结果(肩峰-大结节角 [AGA]和肱骨外侧偏移 [LO])。还评估了肱骨和肩胛盂组件周围的透亮线(RLL)和松动情况。
两组患者术后临床结果均改善(均 p<0.001)。两组术后测量的旋转弧均增大(均 p<0.001),但肩胛盂组件类型对 AGA 和 LO 无影响(均 p>0.05)。PE 和 MB 组的总体并发症发生率包括 RLL 分别为 43.8%(14/32)和 16.7%(3/18)(p=0.031)。尽管 PE 组的 RLL 多于 MB 组(p<0.05),但两组均未出现与 RLL 相关的症状和/或肩胛盂植入物松动。PE 组有 2 例和 MB 组有 1 例发生肩胛下肌失败。
带维生素 E1 涂层衬垫的可转换金属背衬肩胛盂植入物可能是一种较好的选择,因为它具有更容易转换为反式全肩关节置换术的潜力。